Virsik Peter

Chief Operating Officer at ESSA Pharma Inc.

Sold, on record
$819k
Dollars the filings state
Form 4 sales
10
Latest Oct 7, 2024
Form 144 notices
3
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ESSA Pharma Inc.Unusual
    Feb 6 2024

    Sold 72,782 shares at $10.29 ($749k)

    Virsik Peter, Chief Operating Officer

    10b5-1 planSold 84.5% of holdings ($886k position)13,328 shares left61x usual sizeFollows a Form 144Filing

  2. 2 Form 4 sale ESSA Pharma Inc.Routine
    Mar 5 +28 days

    Sold 694 shares at $8.98 ($6k)

    Virsik Peter, Chief Operating Officer

    10b5-1 planSold 5.2% of holdings ($120k position)12,634 shares left0.5x usual sizeFollows a Form 144Filing

  3. 3 Form 144 notice ESSA Pharma Inc.Notice
    Apr 5 +31 days

    Filed to sell 2,082 shares ($17k)

    Virsik Peter, Officer

    10b5-1 plan1.7x usual sizeFiling

  4. 4 Form 4 sale ESSA Pharma Inc.Routine
    Apr 5 same day

    Sold 694 shares at $7.94 ($6k)

    Virsik Peter, Chief Operating Officer

    10b5-1 planSold 5.5% of holdings ($100k position)11,940 shares left0.6x usual sizeFollows a Form 144Filing

  5. 5 Form 4 sale ESSA Pharma Inc.Routine
    May 6 +31 days

    Sold 694 shares at $6.95 ($5k)

    Virsik Peter, Chief Operating Officer

    10b5-1 planSold 5.8% of holdings ($83k position)11,246 shares left0.7x usual sizeFollows a Form 144Filing

  6. 6 Form 4 sale ESSA Pharma Inc.Routine
    Sep 3 +120 days

    Sold 2,082 shares at $6.03 ($13k)

    Virsik Peter, Chief Operating Officer

    10b5-1 planSold 18.5% of holdings ($68k position)9,164 shares left3x usual sizeFiling

  7. 7 Form 4 sale ESSA Pharma Inc.Routine
    Sep 9 +6 days

    Sold 694 shares at $6.00 ($4k)

    Virsik Peter, Chief Operating Officer

    10b5-1 planSold 7.6% of holdings ($55k position)8,470 shares left0.7x usual sizeFiling

  8. 8 Form 4 sale ESSA Pharma Inc.Routine
    Oct 7 +28 days

    Sold 694 shares at $6.03 ($4k)

    Virsik Peter, Chief Operating Officer

    10b5-1 planSold 8.2% of holdings ($51k position)7,776 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (13)

Form 144 notices and Form 4 sales by Virsik Peter
Source
Oct 7, 2024ESSA Pharma Inc.Chief Operating OfficerForm 4 sale694$4k8.2%RoutineSEC
Sep 9, 2024ESSA Pharma Inc.Chief Operating OfficerForm 4 sale694$4k7.6%RoutineSEC
Sep 3, 2024ESSA Pharma Inc.Chief Operating OfficerForm 4 sale2,082$13k18.5%RoutineSEC
May 6, 2024ESSA Pharma Inc.Chief Operating OfficerForm 4 sale694$5k5.8%RoutineSEC
Apr 5, 2024ESSA Pharma Inc.Chief Operating OfficerForm 4 sale694$6k5.5%RoutineSEC
Apr 5, 2024ESSA Pharma Inc.OfficerForm 144 notice2,082$17kNoticeSEC
Mar 5, 2024ESSA Pharma Inc.Chief Operating OfficerForm 4 sale694$6k5.2%RoutineSEC
Feb 6, 2024ESSA Pharma Inc.Chief Operating OfficerForm 4 sale72,782$749k84.5%UnusualSEC
Feb 5, 2024ESSA Pharma Inc.Chief Operating OfficerForm 4 sale1,194$11k8.2%RoutineSEC
Jan 16, 2024ESSA Pharma Inc.Chief Operating OfficerForm 4 sale1,718$17k10.9%RoutineSEC
Jan 16, 2024ESSA Pharma Inc.OfficerForm 144 notice75,000$746kNoticeSEC
Jan 5, 2024ESSA Pharma Inc.Chief Operating OfficerForm 4 sale699$4k4.7%RoutineSEC
Jan 5, 2024ESSA Pharma Inc.OfficerForm 144 notice2,087$13kNoticeSEC